retatrutide fda The has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, FDA warns against unapproved drugs
Description
Super Carnitine GBBGO Turning Up The Heat on Fat
Consumers are also advised that injectable products may also be improperly sterilized, leading to infections and allergic reactions among other issues

Free consultations!

You've seen the ads: "$99/month for semaglutide!" "$149 to start tirzepatide!" Sounds reasonable, so you sign up, do everything right, and your dose goes up

Don't mistake weight loss for health gain, especially in the GLP1 era